Cancer-on-a-Chip: Applications and Challenges

Dear Colleague,

Cancer-on-a-chip platforms arise from the convergence of microfabrication and tissue engineering with the potentiality to replicate key aspects of cancer and identify molecular, cellular and biophysical features of human cancer progression. Additionally, it can address the current limitation of animal models and cells. Due to these features, organs-on-a-chip platforms are emerging as one of the fastest growing research areas, promising to become a multi-billion dollars industry. Although the potentiality to enhance personalized medicine, understand drug effects and improve preclinical safety and efficacy of new biomaterials, this technology is still in its infancy and many challenges need to be suppressed. In this sense, this Special Issue on Cancer-on-a-chip: applications and challenges, seeks to gather the ultimate breakthroughs and innovative development techniques done in this multidisciplinary area, aiming to an end-use of this technology. In this Special Issue, we invite contributions (original research papers, review articles, and short communications) that focus on the latest advances and challenges in cancer-on-a-chip platforms and related research areas applied to the development of this field.

Dr. Raquel Rodrigues
Prof. Graça Minas
Prof. Stefan Krauss
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.